Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT01457924 · COMPLETED
Trial details
- NCT number
- NCT01457924
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-08-23
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.